FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

I thought I had an allergy to alcohol when I saw my cheeks flush bright red after a drink, but it turns out there's a unique ...

The Marshall Project reports that multiple states are introducing bills to protect patients from drug testing at childbirth, ...

Dipanwita Das, CEO and co-founder of Sorcero, chats with Pharma Commerce to dig into the evolving drug development landscape, ...

Judge Joshua Roberts entered an opinion Tuesday on his denial of a motion for his recusal from the Philadelphia Zantac mass tort. The plaintiffs in the Philadelphia Zantac mass tort had requested ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

Zantac’s Developer Settles Lawsuits Claiming Cancer Link GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

Plaintiffs in Philadelphia's Zantac mass tort are asking the judge overseeing the litigation to recuse himself. The motion is based on the judge's wife's role as partner at a firm that represents ...